Press releases

Single-use system for stone removal eliminates maintenance, reprocessing and sterilization

Study demonstrates spinal cord stimulation device provided significant decrease in average pain scores sustained over a two-year period

Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe

First implants occur in Europe, commencing limited market release

For the second consecutive year, Boston Scientific is named one of the "Best Places to Work for LGBT Equality"

Transaction to expand interventional oncology portfolio with drug-eluting microspheres and spherical embolics

"Our excellent third quarter performance was driven by strong sales and differentiated adjusted operating margin expansion," said CEO Mike Mahoney

Investment continues alliance for percutaneous mitral valve replacement established in 2012

Up to $25,000 in prizes to be awarded to winners

New category of drug-eluting stent approved for U.S. patients

Provides minimally invasive alternative to an esophagectomy

MAJESTIC trial data support strong safety profile with low target lesion revascularization rate

System includes first directional lead with current steering and expanded programming flexibility

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems

U.S. launch underway for therapy designed to treat Peripheral Artery Disease

Men’s health and prostate health acquisition positions Boston Scientific as a urology leader

Strategic alliance to expand Boston Scientific portfolio of remote monitoring solutions

"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.

First guidewire designed specifically for TAVI/R now sized for smaller ventricles

First Patients Enrolled in the FAST Feasibility Study

Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma

Study to evaluate patients implanted with S-ICD for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function

Spinal cord stimulator (SCS) system provided 1.5x better overall pain relief and 2x better low back pain relief than previous generation system

World's smallest 16-contact high-capacity primary cell device expands spinal cord stimulator system (SCS) offering

Compelling results presented at EuroPCR 2015 add to growing body of evidence supporting performance and safety